Method for detecting cancer cells and monitoring cancer therapy
    3.
    发明申请
    Method for detecting cancer cells and monitoring cancer therapy 有权
    检测癌细胞和监测癌症治疗的方法

    公开(公告)号:US20050152838A1

    公开(公告)日:2005-07-14

    申请号:US10920030

    申请日:2004-08-16

    摘要: Disclosed herein are methods for identifying cancer cells and monitoring anti-cancer therapy in the body of a mammal by systemically delivering Sindbis viral vectors. The vector can specifically target and identify tumor cells in mice growing subcutaneously, intraperitoneally, intrapancreatically, or in the lungs. These findings demonstrate the remarkable specificity of the Sindbis vector system that is relatively safe and can specifically target tumor cells throughout the body via the bloodstream.

    摘要翻译: 本文公开了通过系统地递送辛德毕斯病毒载体来鉴定癌细胞并监测哺乳动物身体中的抗癌疗法的方法。 载体可以特异性靶向和鉴定在皮下,腹膜内,胰腺内或肺内生长的小鼠中的肿瘤细胞。 这些研究结果表明,辛比比斯载体系统的显着特异性是相对安全的,可以通过血液特异性靶向整个人体的肿瘤细胞。

    Method for detecting cancer cells and monitoring cancer therapy
    4.
    发明授权
    Method for detecting cancer cells and monitoring cancer therapy 有权
    检测癌细胞和监测癌症治疗的方法

    公开(公告)号:US07910093B2

    公开(公告)日:2011-03-22

    申请号:US10920030

    申请日:2004-08-16

    IPC分类号: A01N63/00 A61K48/00 C12Q1/68

    摘要: Disclosed herein are methods for identifying cancer cells and monitoring anti-cancer therapy in the body of a mammal by systemically delivering Sindbis viral vectors. The vector can specifically target and identify tumor cells in mice growing subcutaneously, intraperitoneally, intrapancreatically, or in the lungs. These findings demonstrate the remarkable specificity of the Sindbis vector system that is relatively safe and can specifically target tumor cells throughout the body via the bloodstream.

    摘要翻译: 本文公开了通过系统地递送辛德毕斯病毒载体来鉴定癌细胞并监测哺乳动物身体中的抗癌疗法的方法。 载体可以特异性靶向和鉴定在皮下,腹膜内,胰腺内或肺内生长的小鼠中的肿瘤细胞。 这些研究结果表明,辛比比斯载体系统的显着特异性是相对安全的,可以通过血液特异性靶向整个人体的肿瘤细胞。

    TUMOR THERAPY WITH NON-VIRAL-BASED HIGH AFFINITIY LAMININ RECEPTOR-TARGETED VECTORS
    6.
    发明申请
    TUMOR THERAPY WITH NON-VIRAL-BASED HIGH AFFINITIY LAMININ RECEPTOR-TARGETED VECTORS 审中-公开
    肿瘤治疗与非基于病毒的高亲和层粘蛋白受体靶向载体

    公开(公告)号:US20090081283A1

    公开(公告)日:2009-03-26

    申请号:US12270230

    申请日:2008-11-13

    申请人: Daniel Meruelo

    发明人: Daniel Meruelo

    摘要: The present invention relates to methods and compositions for treating tumors using vectors that preferentially target tumor cells. In particular, the invention relates to alphavirus-based, preferably Sindbis virus-based, vectors and to non-alphavirus-based vectors, which have a preferential affinity for high affinity laminin receptors (HALR). These vectors are efficiently targeted to tumors and have the ability to cause tumor necrosis.

    摘要翻译: 本发明涉及使用优先靶向肿瘤细胞的载体治疗肿瘤的方法和组合物。 特别地,本发明涉及对高亲和层粘连蛋白受体(HALR)具有优先亲和力的基于甲病毒的,优选基于辛德比斯病毒的载体和非甲病毒属的非载体。 这些载体有效靶向肿瘤并具有引起肿瘤坏死的能力。

    TUMOR THERAPY WITH HIGH AFFINITY LAMININ RECEPTOR-TARGETED VECTORS AND COMPOUNDS
    10.
    发明申请
    TUMOR THERAPY WITH HIGH AFFINITY LAMININ RECEPTOR-TARGETED VECTORS AND COMPOUNDS 审中-公开
    具有高亲和力层粘连蛋白受体靶向载体和化合物的肿瘤治疗

    公开(公告)号:US20090081131A1

    公开(公告)日:2009-03-26

    申请号:US12270150

    申请日:2008-11-13

    申请人: Daniel Meruelo

    发明人: Daniel Meruelo

    摘要: The present invention relates to methods and compositions for treating tumors using vectors that preferentially target tumor cells. In particular, the invention relates to alphavirus-based, preferably Sindbis virus-based, vectors and to non-alphavirus-based vectors, which have a preferential affinity for high affinity laminin receptors (HALR). These vectors are efficiently targeted to tumors and have the ability to cause tumor necrosis.

    摘要翻译: 本发明涉及使用优先靶向肿瘤细胞的载体治疗肿瘤的方法和组合物。 特别地,本发明涉及对高亲和层粘连蛋白受体(HALR)具有优先亲和力的基于甲病毒的,优选基于辛德比斯病毒的载体和非甲病毒属的非载体。 这些载体有效靶向肿瘤并具有引起肿瘤坏死的能力。